DH calls for further consideration on Alzheimer’s drugs proposals

The government has asked the National Institute for Clinical Excellence (NICE) to take carer time into consideration in its study of the cost effectiveness of the country’s main Alzheimer’s drugs.Responding to the independent body’s consultation paper suggesting the withdrawal of donepezil, rivastigmine, galantamine and memantine, Health Secretary John Reid has asked NICE to seriously consider…